Rationale and design of a phase III safety trial of idarucizumab in children receiving dabigatran etexilate for venous thromboembolism

ESSENTIALS: There is no data on the use of idarucizumab in children with venous thromboembolism (VTE). We present the design of a trial that will assess the safety of idarucizumab in children with VTE. Patients will be recruited from two ongoing trials in children treated with dabigatran for VTE. Id...

Descripción completa

Detalles Bibliográficos
Autores principales: Albisetti, Manuela, Schlosser, Arno, Brueckmann, Martina, Gropper, Savion, Glund, Stephan, Tartakovsky, Igor, Brandão, Leonardo R., Reilly, Paul A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles: Thrombosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868044/
https://www.ncbi.nlm.nih.gov/pubmed/30046708
http://dx.doi.org/10.1002/rth2.12053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868044/
https://www.ncbi.nlm.nih.gov/pubmed/30046708
http://dx.doi.org/10.1002/rth2.12053

Ejemplares similares